Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-355,726
Closed -$8.27M 219
2023
Q4
$8.27M Sell
355,726
-222,092
-38% -$4.47M 0.71% 42
2023
Q3
$11.4M Buy
577,818
+50,000
+9% +$985K 1.33% 13
2023
Q2
$12M Buy
527,818
+10,282
+2% +$207K 1.25% 13
2023
Q1
$10.2M Buy
517,536
+61,377
+13% +$1.18M 1.21% 18
2022
Q4
$7.85M Buy
+456,159
New +$8.09M 1.15% 15

Other funds holding RXO

Crestline Management's RXO Position: Q1 2024 in Review

Crestline Management sold out of RXO (RXO) in Q1 2024, closing a stake of 355,726 shares — an estimated $8.27M sold.

Crestline Management first reported a position in RXO in Q4 2022 and held it in 5 quarters. The position peaked at $12M in Q2 2023. 241 funds tracked by Wall St. Rank hold RXO as of Q1 2024.

  • Crestline Management reported no remaining RXO position as of Q1 2024 after selling out during the quarter.
  • Crestline Management sold 355,726 RXO shares in Q1 2024, an estimated $8.27M.
  • Crestline Management first reported a position in RXO in Q4 2022 and held it in 5 quarters.
  • Crestline Management's RXO position peaked at $12M in Q2 2023.
  • 241 funds tracked by Wall St. Rank held RXO as of Q1 2024.

Based on Crestline Management's 13F filing for Q1 2024, filed 14 May 2024.